RECEIVABLES FINANCING AGREEMENT dated as of June 19, 2020 among Corona Diagnostics LLC, Todos Medical USA and Todos Medical Ltd., As Borrower, and Toledo Advisors L.L.C., As Lender RECEIVABLES FINANCING AGREEMENTReceivables Financing Agreement • March 31st, 2022 • Todos Medical Ltd. • Surgical & medical instruments & apparatus • Nevada
Contract Type FiledMarch 31st, 2022 Company Industry JurisdictionThis Receivables Financing Agreement (as amended, restated, supplemented or otherwise modified, this “Agreement”) is entered into between Toledo Advisors L.L.C., a Nevada limited liability company with its principal place of business at 641 5th Street, Lakewood, NJ 08701 (together with its successors, the “Lender”), and Corona Diagnostics LLC, a Nevada limited liability company (the “Testing Sub”), Todos Medical USA, a Nevada corporation (the “Holding Company”), and Todos Medical Ltd., an Israeli corporation (the “Parent” and jointly and severally with Testing Sub and the Holding Company, the “Borrower”), each with a mailing address of 45 Wall Street, Suite 920, New York, NY 10005, as of the 19th day of June, 2020 (the “Effective Date”).
AMENDMENT NO.1 TO BINDING JOINT VENTURE AGREEMENTBinding Joint Venture Agreement • March 31st, 2022 • Todos Medical Ltd. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 31st, 2022 Company Industry JurisdictionThis AMENDMENT NO. 1 (the “Amendment”) to the BINDING JOINT VENTURE AGREEMENT (the “Agreement”) originally entered into as of November 24, 2018, by and between Amarantus Bioscience Holdings, Inc. (“Amarantus”) and Todos Medical, Ltd., an Israel corporation (“Todos” or the “Company”) is made effective as of July __, 2020. Capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.
Distribution AgreementDistribution Agreement • March 31st, 2022 • Todos Medical Ltd. • Surgical & medical instruments & apparatus
Contract Type FiledMarch 31st, 2022 Company IndustryThis Distribution Agreement (the “Agreement”) is made and entered into on this 22th day of July, 2020 (the “Effective Date”) by and between TODOS Medical USA, Inc., a company registered under the laws of the state of Nevada in the United States, with its principal address of business located at 45 Wall Street, Suite 920, New York, NY 10005 (hereinafter referred to as “TODOS”), and PCL Inc, , a company registered under the laws of Korea, with its principal address of business located at 701 Star Valley, Gasan Digital Complex, Seoul, Korea (hereinafter referred to as “PCL”, and together with TODOS, the “Parties” and each individually, a “Party”).